JNJ trade ideas
JNJ Road Ahead20171017 - Product Pipeline
"apalutamide (ARN-509) - Prostate cancer pre-metastatic castration-resistant" - Phase III
20171221 - U.S. FDA Grants Priority Review to Janssen for Apalutamide as a Treatment for Non-Metastatic Castration-Resistant Prostate Cancer
Apalutamide is an investigational, next-generation oral androgen receptor inhibitor that inhibits the action of androgen in prostate cancer cells, and prevents binding of androgen to the androgen receptor, and translocation of the androgen receptor to the nucleus of the cancer cell.
20180118 - with Pfizer in hot pursuit, JNJ loses a critical patent fight as it scrambles for a new prostate cancer drug OK
If J&J loses this battle, it still has a late-stage drug in front of the FDA — apalutamide, or ARN-509 — it’s hoping can protect the big revenue stream it gets from Zytiga (abiraterone), an oral drug that has helped revolutionize prostate cancer treatment over the last 5 years.
J&J won a priority review of apalutamide for nonmetastatic castration resistant prostate cancer, an early designation. And it’s fielding Phase III data that is slated to be revealed at the ASCO Genitourinary Cancers Symposium on February 8. The accelerated PDUFA date is in April.
Looking at the support levels for JNJ to bounce atI drew two support levels where JNJ could bounce off of. I'll be watching how the candles form over the next few days. For my daily trading log, you can view them here: www.youtube.com
JNJ put saleJNJ had a massive move down on their earnings. This is one of the largest candles I can even find on the chart for JNJ. As is approached the 50EMA I was looking for Bull Put Spread or Put Sale premium. Because of dividends being at the end of February and the 200 SMA down around 134. It seems like a no brainer.
JOHNSON & JOHNSON PULL BACK TO SUPPORT OF ITS TRIANGLE-LONGJ&J STOCK, AFTER BREAKS UP A TRIANGLE PATTERN IS PULLING BACK TO SUPPORT AT 137.25, WHICH GIVE A GOOD OPPORTUNITY TO ENTER .
I AM EXPECTING THE STOCK HOLDS AT SUPPORT AND BOUNCE. THE INITIAL TARGET COULD BE 145, WHICH IS THE 200% OF FIBONACCI EXTENSION OF THE PREVIOUS LOW.
HOWEVER, THE TRIANGLE CALL FOR A LONG TERM TARGET OF 151-152 MINIMUM.
IF THE STOCK PRICE BREAKS SUPPORT DOWN FOR A GOOD MARGIN, THE STOP LOSS IS SET UP AT 134.
THIS ANALYSIS IS FOR EDUCATION PURPOSES.
GOOD LUCK!!!!
www.tradingview.com
JNJ Stochastic Divergence Falling Wedge Breakout
JNJ has stochastic divergence (1h) at the breakout point of a falling edge.
Buy: 138.34
Target: 140.27 - 141.83 (1.40% - 2.52%)
Stocks that have raised dividends for at least 25 Years11/18/17 - JNJ has been on a majestic bullish power trend since 03/09.
You can't be anything but bullish long-term. If we were trying to time the market or at least get a better price, we might want to wait for a 10% pullback to the most recent pivot high of 123-126ish from August 2016. If that area of 123-126 is taken out I would be more bearish than bullish with the next lower target area of 109-113ish. As a strong fundamental company that has increased dividends every year for 54 straight years and is stable during a recession, this is a great company to own for your portfolio. Current Forward Dividend & Yield is 3.36 (2.37%).
Classic Bounce after breakoutShe broke out with higher than average "bullish" volume and is currently coming down to re-test that new support on lower "bearish" volume. It might hang around this price level for a bit, but Its a good opportunity to go long around 136-138. If it manages to hold on this support level, you will see higher prices as it can continue on the upward trend channel. If not, you will probably see it come down to that 128 level.
Johnson & Johnson Long Setupgreat opportunity to buy and hold good accumulated from smart money and good effort departure area of re accumulation targeting 152$ then 164$
JNJ Elliott WaveLooking for a long Wave 3 to continue higher from here. There was some nice sideways action over the last few moths. Earnings came out on October 17th, sending price right through the old resistance, and initiating what I believe was leg 1 of another 5 wave move.
JNJ - RiskReversal on Johnson & JohnsonThis is my first trade I post not only here, but also on my new blog (see footer) & chat here on TV.
I start this group education on TV because I see how many traders could be more successful, if they only had more knowledge, how to trade by combining high probability strategies.
My method is the combination of the Forks and Options.
But I also trade 100% directional with the underlying, leaning on my one strategy.
If you like my style, then join the ForkTrading Method chat here on TV.
The chart shows you how I combine my Forks with Options.
Currently I see a bounce to the downside, as price leaves the Centerline.
I post a detailed description about the trade with a PNL graph on my website (see footer), so I can keep the chat as clean and lean as possible.
Always appreciate your comments, questions and constructive criticism too ;-)
P!
JNJ Good opportunity with high R/R, break out tradeHi,
The title is bullish, but now we have a small congestion.
We must await until the break out for trade, if the price goes up than we can follow the trend. If the price goes down we can make profit with the retracement.
Every levels are drawn on the imagine.
Johnson & johnson Missing a leg up?Looks like Johnson & johnson (JNJ) is heading up, to complete a 5 th wave target of 129.05$. a close below 112$ would invalidate the scenario.
Breakout & Waiting for retest to buy & hodlElliott Wave, Supply and Demand, Support and Resistance, Parallel Channel, Cup & Handle.
